A Phase II Study Of Perifosine In Patients With Recurrent Or Metastatic Head And Neck Cancer.

Trial Profile

A Phase II Study Of Perifosine In Patients With Recurrent Or Metastatic Head And Neck Cancer.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 01 Mar 2013

At a glance

  • Drugs Perifosine (Primary)
  • Indications Head and neck cancer
  • Focus Adverse reactions; Biomarker; Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 01 Mar 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 12 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Apr 2009 Actual end date Jan 2007 added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top